Cancer Research Cancer Public Health Clinical Trials Patient Care Medical Treatments Immunotherapy Health Policy Vaccination Programs Health Disparities
The iSCIB1+ vaccine leverages immunotherapy to target advanced melanoma, with patient recruitment set to begin across England in the coming month.